The Nordic pharmaceutical market continued its strong growth during the period February–October 2007. On average the market growth was 6.7% compared to 3.8% for the same period last year. However, fierce competition kept the margins low. The wholesale margins are extremely modest compared to the margins of the other parties in the pharmaceutical value chain.

The Baltic markets continued to post good growth as well. The average market growth was 17.6%. These markets are characterised by higher inflation and unclear economic growth. In spite of the good growth, pharmaceutical consumption and reimbursement is far below the EU average. The Polish market grew by 10 %, however, political uncertainties, also being manifested by new challenging pharmacy legislation, tell the market players that major measures still have to be installed.